Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis (original) (raw)

• Espinal, M.A. The global situation of MDR-TB. Tuberculosis (Edinb.) 83, 44–51 (2003).
  Article Google Scholar
• Mondal, R. & Jain, A. Extensively drug-resistant Mycobacterium tuberculosis, India. Emerg. Infect. Dis. 13, 1429–1431 (2007).
  Article PubMed PubMed Central Google Scholar
• Caminero, J.A., Sotgiu, G., Zumla, A. & Migliori, G.B. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect. Dis. 10, 621–629 (2010).
  Article CAS PubMed Google Scholar
• Kroon, A.M. & Van den Bogert, C. Antibacterial drugs and their interference with the biogenesis of mitochondria in animal and human cells. Pharm. Weekbl. Sci. 5, 81–87 (1983).
  CAS PubMed Google Scholar
• Kohanski, M.A., Dwyer, D.J. & Collins, J.J. How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol. 8, 423–435 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Wei, J.R. et al. Depletion of antibiotic targets has widely varying effects on growth. Proc. Natl. Acad. Sci. USA 108, 4176–4181 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Jovetic, S., Zhu, Y., Marcone, G.L., Marinelli, F. & Tramper, J. β-Lactam and glycopeptide antibiotics: first and last line of defense? Trends Biotechnol. 28, 596–604 (2010).
  Article CAS PubMed Google Scholar
• Khoo, K.H. et al. Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol. J. Biol. Chem. 271, 28682–28690 (1996).
  Article CAS PubMed Google Scholar
• Vilchèze, C. et al. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat. Med. 12, 1027–1029 (2006).
  Article PubMed CAS Google Scholar
• Slayden, R.A. et al. Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis. Antimicrob. Agents Chemother. 40, 2813–2819 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Glickman, M.S., Cox, J.S. & Jacobs, W.R. Jr. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol. Cell 5, 717–727 (2000).
  Article CAS PubMed Google Scholar
• Dubnau, E. et al. Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol. Microbiol. 36, 630–637 (2000).
  Article CAS PubMed Google Scholar
• Bhatt, A., Molle, V., Besra, G.S., Jacobs, W.R. Jr. & Kremer, L. The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development. Mol. Microbiol. 64, 1442–1454 (2007).
  Article CAS PubMed Google Scholar
• Kremer, L., Baulard, A.R. & Besra, G.S. Genetics of mycolic acid biosynthesis. in Molecular Genetics of Mycobacteria (eds. Hatfull, G.F. & Jacobs, W.R. Jr.) 173–190 (ASM Press, 2000).
• Takayama, K., Wang, C. & Besra, G.S. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev. 18, 81–101 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Barry, C.E. III et al. Mycolic acids: structure, biosynthesis and physiological functions. Prog. Lipid Res. 37, 143–179 (1998).
  Article CAS PubMed Google Scholar
• Brennan, P.J. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 83, 91–97 (2003).
  Article CAS Google Scholar
• Ojha, A.K., Trivelli, X., Guerardel, Y., Kremer, L. & Hatfull, G.F. Enzymatic hydrolysis of trehalose dimycolate releases free mycolic acids during mycobacterial growth in biofilms. J. Biol. Chem. 285, 17380–17389 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Gavalda, S. et al. The Pks13/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis. J. Biol. Chem. 284, 19255–19264 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Portevin, D. et al. A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. Proc. Natl. Acad. Sci. USA 101, 314–319 (2004).
  Article CAS PubMed Google Scholar
• Léger, M. et al. The dual function of the Mycobacterium tuberculosis FadD32 required for mycolic acid biosynthesis. Chem. Biol. 16, 510–519 (2009).
  Article PubMed CAS Google Scholar
• Carroll, P., Faray-Kele, M.C. & Parish, T. Identifying vulnerable pathways in Mycobacterium tuberculosis by using a knockdown approach. Appl. Environ. Microbiol. 77, 5040–5043 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Sassetti, C.M. & Rubin, E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. USA 100, 12989–12994 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Alland, D., Steyn, A.J., Weisbrod, T., Aldrich, K. & Jacobs, W.R. Jr. Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition. J. Bacteriol. 182, 1802–1811 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Maddry, J.A. et al. Antituberculosis activity of the molecular libraries screening center network library. Tuberculosis (Edinb.) 89, 354–363 (2009).
  Article CAS Google Scholar
• Ananthan, S. et al. High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis (Edinb.) 89, 334–353 (2009).
  Article CAS Google Scholar
• Tahlan, K. et al. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 56, 1797–1809 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Telenti, A. et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat. Med. 3, 567–570 (1997).
  Article CAS PubMed Google Scholar
• Onodera, Y., Tanaka, M. & Sato, K. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 47, 447–450 (2001).
  Article CAS PubMed Google Scholar
• Trivedi, O.A. et al. Enzymic activation and transfer of fatty acids as acyl-adenylates in mycobacteria. Nature 428, 441–445 (2004).
  Article CAS PubMed Google Scholar
• Freundlich, J.S. et al. Triclosan derivatives: towards potent inhibitors of drug-sensitive and drug-resistant Mycobacterium tuberculosis. ChemMedChem 4, 241–248 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Reddy, V.M., Einck, L., Andries, K. & Nacy, C.A. In vitro interactions between new antitubercular drug candidates SQ109 and TMC207. Antimicrob. Agents Chemother. 54, 2840–2846 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Siddiqi, S.H., Libonati, J.P. & Middlebrook, G. Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 13, 908–912 (1981).
  CAS PubMed PubMed Central Google Scholar
• Safi, H., Sayers, B., Hazbon, M.H. & Alland, D. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob. Agents Chemother. 52, 2027–2034 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Middlebrook, G. Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro. Am. Rev. Tuberc. 65, 765–767 (1952).
  CAS PubMed Google Scholar
• Siddiqi, S., Takhar, P., Baldeviano, C., Glover, W. & Zhang, Y. Isoniazid induces its own resistance in nonreplicating Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51, 2100–2104 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Gumbo, T. et al. Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations. Antimicrob. Agents Chemother. 51, 2329–2336 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Gumbo, T. et al. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth. J. Infect. Dis. 195, 194–201 (2007).
  Article CAS PubMed Google Scholar
• Wallis, R.S. et al. Drug tolerance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43, 2600–2606 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Falzari, K. et al. In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49, 1447–1454 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Boechat, N. et al. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain. J. Med. Chem. 54, 5988–5999 (2011).
  Article CAS PubMed Google Scholar
• Morris, G.M. et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785–2791 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Trott, O. & Olson, A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455–461 (2010).
  CAS PubMed PubMed Central Google Scholar
• Šali, A. & Blundell, T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779–815 (1993).
  Article PubMed Google Scholar
• Phetsuksiri, B. et al. Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis. Antimicrob. Agents Chemother. 43, 1042–1051 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Kremer, L. et al. Inhibition of InhA activity, but not KasA activity, induces formation of a KasA-containing complex in mycobacteria. J. Biol. Chem. 278, 20547–20554 (2003).
  Article CAS PubMed Google Scholar
• Roujeinikova, A. et al. X-ray crystallographic studies on butyryl-ACP reveal flexibility of the structure around a putative acyl chain binding site. Structure 10, 825–835 (2002).
  Article CAS PubMed Google Scholar
• Parris, K.D. et al. Crystal structures of substrate binding to Bacillus subtilis holo-(acyl carrier protein) synthase reveal a novel trimeric arrangement of molecules resulting in three active sites. Structure 8, 883–895 (2000).
  Article CAS PubMed Google Scholar
• Lee, R.E. et al. Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates. J. Comb. Chem. 5, 172–187 (2003).
  Article CAS PubMed Google Scholar
• Jackson, M., Crick, D.C. & Brennan, P.J. Phosphatidylinositol is an essential phospholipid of mycobacteria. J. Biol. Chem. 275, 30092–30099 (2000).
  Article CAS PubMed Google Scholar
• Veyron-Churlet, R., Zanella-Cleon, I., Cohen-Gonsaud, M., Molle, V. & Kremer, L. Phosphorylation of the Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein reductase MabA regulates mycolic acid biosynthesis. J. Biol. Chem. 285, 12714–12725 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Stover, C.K. et al. New use of BCG for recombinant vaccines. Nature 351, 456–460 (1991).
  Article CAS PubMed Google Scholar
• Kim, P. et al. Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships. J. Med. Chem. 52, 1329–1344 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• van Soolingen, D., Hermans, P.W., de Haas, P.E., Soll, D.R. & van Embden, J.D. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29, 2578–2586 (1991).
  CAS PubMed PubMed Central Google Scholar
• Slayden, R.A. & Barry, C.E. III. Analysis of the lipids of Mycobacterium tuberculosis. Methods Mol. Med. 54, 229–245 (2001).
  CAS PubMed Google Scholar
• Seeliger, J.C. et al. Elucidation and chemical modulation of sulfolipid-1 biosynthesis in Mycobacterium tuberculosis. J. Biol. Chem. 287, 7990–8000 (2012).
  Article CAS PubMed Google Scholar
• Domenech, P. & Reed, M.B. Rapid and spontaneous loss of phthiocerol dimycocerosate (PDIM) from Mycobacterium tuberculosis grown in vitro: implications for virulence studies. Microbiology 155, 3532–3543 (2009).
  Article CAS PubMed Google Scholar
• Alibaud, L. et al. A Mycobacterium marinum TesA mutant defective for major cell wall–associated lipids is highly attenuated in Dictyostelium discoideum and zebrafish embryos. Mol. Microbiol. 80, 919–934 (2011).
  Article CAS PubMed Google Scholar
• DeLano, W.L. The PyMOL Molecular Graphics System (DeLano Scientific, San Carlos, California, USA, 2002).